Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato

The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...

1 year ago
Clinical Development,Clinical Operations

Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato

The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...

1 year ago

Using Translational Research to Bridge the Gap Between Preclinical and Clinical Research

The disparity between animal models and clinical efficacy is compromising the safety and efficacy of therapeutic drugs. Translational research is building the bridge between preclinical studies and therapeutic treatment. Genomic techniques and non-traditional animal models are examples of translational approaches...

1 year ago
Clinical Development,Clinical Operations,R&D,Biology,News

Using Translational Research to Bridge the Gap Between Preclinical and Clinical Research

The disparity between animal models and clinical efficacy is compromising the safety and efficacy of therapeutic drugs. Translational research is building the bridge between preclinical studies and therapeutic treatment. Genomic techniques and non-traditional animal models are examples of translational approaches...

1 year ago

Understanding the GP Data Extraction Scheme & Use of Patient Data

The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...

1 year ago
Clinical Development,Clinical Operations,Data,News

Understanding the GP Data Extraction Scheme & Use of Patient Data

The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...

1 year ago

How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?

As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...

1 year ago
Oncology,Clinical Operations,Biology,News

How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?

As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...

1 year ago

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

1 year ago
Clinical Operations,Race and Ethics,Precision and Personalised Medicine,Biology,News

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

1 year ago

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

1 year ago
Clinical Operations,AI & ML

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

1 year ago

The Impact of Modern Technology on Clinical Operations

The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...

1 year ago
Bioinformatics,Clinical Operations,AI & ML,Biology,News

The Impact of Modern Technology on Clinical Operations

The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...

1 year ago

Real World Data and Evidence: Emerging Trends Across Clinical Research

Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...

1 year ago
Bioinformatics,Clinical Operations,Biology,News

Real World Data and Evidence: Emerging Trends Across Clinical Research

Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...

1 year ago

Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs

Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...

1 year ago
Oncology,Clinical Operations,Biology,News

Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs

Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...

1 year ago

The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer

In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases -  paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...

1 year ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine,Biology,News

The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer

In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases -  paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...

1 year ago